Pleomorphic adenoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
The annual incidence of | The annual incidence of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population. It accounts for 45-75% of all salivary gland neoplasms. Females are more commonly affected than males. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 19:52, 22 January 2019
|
Pleomorphic adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pleomorphic adenoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pleomorphic adenoma epidemiology and demographics |
|
Pleomorphic adenoma epidemiology and demographics in the news |
|
Risk calculators and risk factors for Pleomorphic adenoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The annual incidence of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population. It accounts for 45-75% of all salivary gland neoplasms. Females are more commonly affected than males.
Epidemiology and Demographics
Incidence
- The annual incidence of Pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population.[1]
- It accounts for 45-75% of all salivary gland neoplasms.
- Pleomorphic adenoma distribution among the salivary glands is as follows[2]:
- Parotid gland: 84%
- Submandibular gland: 8%
- Minor salivary glands: 6.5%
Age
- People of all age groups may develop Pleomorphic adenoma.[1]
- The incidence of Pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years.
Race
- There is no racial predilection to Pleomorphic adenoma.
Gender
- Females are predominantly affected by Pleomorphic adenoma than males. The female to male ratio is approximately (2:1)
References
- ↑ 1.0 1.1 Pinkston JA, Cole P (June 1999). "Incidence rates of salivary gland tumors: results from a population-based study". Otolaryngol Head Neck Surg. 120 (6): 834–40. doi:10.1016/S0194-5998(99)70323-2.
- ↑ Zhan KY, Khaja SF, Flack AB, Day TA (April 2016). "Benign Parotid Tumors". Otolaryngol. Clin. North Am. 49 (2): 327–42. doi:10.1016/j.otc.2015.10.005. PMID 27040584.